Logically Activatable Nanoreporter for Multiplexed Time-Phased Imaging Assessment of Hepatic Ischemia-Reperfusion Injury and Systemic Inflammation
Hepatic ischemia-reperfusion injury (HIRI) and induced systemic inflammation is a time-dependent multistage process which poses a risk of causing direct hepatic dysfunction and multiorgan failure. Real-time in situ comprehensive visualization assessment is important and scarce for imaging-guided therapeutic interventions and timely efficacy evaluation. Here, a logically activatable nanoreporter (termed QD@IR783-TK-FITC) is developed for time-phase imaging quantification of HIRI and induced systemic inflammation. The nanoreporters could be used for in vivo ratiometric NIR-IIb fluorescence sensing of reactive oxygen species (ROS), which can depict the in situ hepatic ROS fluctuation for the early diagnosis of HIRI in the initial 3 h. Meanwhile, the ROS-specific reaction releases renal-clearable fluorophore fragments from nanoreporters for monitoring the systematic inflammation induced by HIRI via longitudinal urinalysis. In addition, a functional relationship between digitized signal outputs (NIR-IIb ratios, urinary fluorescence) with hepatic injury scores has been established, realizing precise prediction of HIRI severity and preassessment of therapeutic efficacy. Such a time-phased modular toolbox can dynamically report HIRI-induced systemic inflammation in vivo, providing an efficient approach for HIRI treatment.
Authors
- Ran Cui (ORCID: https://orcid.org/0000-0002-1758-4802)
- Zhi‐Jun Sun (ORCID: https://orcid.org/0000-0003-0932-8013)
- Mingxi Zhang (ORCID: https://orcid.org/0000-0002-4311-2737)
- Tao Tang (ORCID: https://orcid.org/0000-0003-2919-2774)
- Biao Huang (ORCID: https://orcid.org/0000-0001-6161-7635)
- Hao Li (ORCID: https://orcid.org/0000-0002-7890-6772)
- Wen‐Ping Lin (ORCID: https://orcid.org/0000-0001-7478-6454)
- Fushou Liu
Institutions
- Wuhan University of Technology (CN)
- Wuhan University (CN)
Publication Details
- Journal
- Analytical Chemistry
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1021/acs.analchem.4c04416
- Citations
- 5
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.92